abstract |
The present invention relates to compositions and methods for use in targeted drug delivery. More particularly, the present invention uses cell surface receptor binding conjugates, including hydrophilic spacer linkers, and such conjugates for use in the treatment of disease states caused by pathogenic cell populations. , Methods and pharmaceutical compositions comprising. |